Home/ Supplements/ Phosphorus/ Whey To Go Whey Protein Powder Vanilla

Whey To Go Whey Protein Powder Vanilla

product on market Powder Solgar Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 20% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Whey protein is supported by strong evidence for promoting muscle protein synthesis and supporting recovery after exercise. The profile focuses on basic macronutrients, which are essential for overall energy and bodily function. Research indicates these components are generally safe and effective for increasing daily protein intake.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Whey To Go Whey Protein Powder Vanilla
Open Full PDF View on NIH DSLD →
Details

Label Data

26 Gram(s)
Serving Size
Amino acid/Protein
Product Type
20%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
100 Calorie(s)
Total Fat
0.5 Gram(s) (1% DV)
Cholesterol
5 mg (2% DV)
Total Carbohydrates
2 Gram(s) (1% DV)
Protein
20 Gram(s) (40% DV)
Calcium
80 mg (8% DV)
40 mg (4% DV)
Within RDA (0.1× RDA) 13 studies (A:0, B:3)
16 mg (4% DV)
Market median: 500.0mg (1 products) 316 studies (A:8, B:159)
Sodium
55 mg (2% DV)
Potassium
115 mg (3% DV)

Other Ingredients

Whey Protein isolate Natural Flavors L-Glutamine Whey Protein concentrate Free-form BCAA's Contains Less Than 1% of
Claims

Label Claims — Verification

Unverified Nutrient
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested use: As a dietary supplement for adults, mix 26 grams in 8 ounces of water, milk, or your favorite juice and blend or shake vigorously. May also be blended with fresh fruit. Please note the additional calories and/or protein provided by milk or juice.

Warnings & Precautions

Notice: Use this product as a food supplement only. Do not use for weight reduction.

If you are pregnant, nursing, taking any medications or have any medical condition, please consult healthcare practitioner before taking any dietary supplement. Discontinue use and consult your healthcare practitioner if any adverse reactions occur.

Keep out of reach of children.

Do not use if packet is torn or open.

Contains milk and soy.

Formulation Notes

rBGH free Gluten free

Mixes easily for smooth taste

No artificial sweeteners

Suitable for lacto-vegetarians

20 g protein < 1 g sugar per serving Vanilla Naturally Flavored With other natural flavors

This product is manufactured from cows not treated with rBGH, recombinant bovine growth hormone. No significant difference has been shown between milk derived from rBGH treated cows and untreated cows.

Additional Information

Store at room temperature.

Typical amino acid profile per serving Essential amino acids L-Histidine 340 mg L-Isoleucine 1474 mg L-Leucine 2243 mg L-Lysine 1845 mg L-Methionine 431 mg L-Phenylalanine 589 mg L-Threonine 1419 mg L-Tryptophan (naturally occuring) 384 mg L-Valine 1319 mg Non essential amino acids L-Alanine 993 mg L-Arginine 411 mg L-Aspartic acid 2184 mg L-Cysteine 412 mg L-Glutamine acid 4744 mg Glycine 319 mg L-Proline 1153 mg L-Serine 885 mg L-Tyrosine 546 mg Approximate values

Metadata

Product Details

DSLD Entry Date2020-06-24
Product TypeAmino acid/Protein
FormPowder
BrandSolgar
DSLD ID228306
Data Updated2026-04-11
Research

Research Evidence

46
Research Sources
55
Avg Quality
23
Meta Analysis
7
Systematic Review
7
Rct
4
Clinical Trial
2
Other
1
Guideline
1
Regulatory Source
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
B Phosphate binders for preventing and treating bone disease in chronic kidney disease patients
Meta Analysis The Cochrane database of systematic reviews 2011 PubMed DOI
B Calcium and phosphorus supplementation of human milk for preterm infants
Systematic Review The Cochrane database of systematic reviews 2017 PubMed DOI
B Radiographic and clinical outcomes of silicate-substituted calcium phosphate (SiCaP) bone grafts in spinal fusion: Systematic review and meta-analysis
Meta Analysis Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2020 PubMed DOI
B ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Calcium, phosphorus and magnesium.
Guideline Clinical nutrition (Edinburgh, Scotland) 2018 PubMed DOI
B Effect of different phosphate binders on fibroblast growth factor 23 levels in patients with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials
Meta Analysis Annals of palliative medicine 2022 PubMed DOI
B Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesia
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
B The impact of phosphate lowering agents on clinical and laboratory outcomes in chronic kidney disease patients: a systematic review and meta-analysis of randomized controlled trials
Meta Analysis Journal of nephrology 2022 PubMed DOI
B Calcimimetics treatment strategy for serum calcium and phosphate management in patients with secondary hyperparathyroidism undergoing dialysis: A systematic review and meta-analysis of randomized studies
Meta Analysis Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2024 PubMed DOI
View all evidence for Phosphorus →
Compare

Similar Products

View all Phosphorus products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.